Ulrike Sager, Stefan Norin, Bastian Hatesuer. "Comprehensive cost analysis of 4th line + therapies for relapsed/refractory multiple myeloma in Germany: Drug, co-medication, and office-based treatment perspective." Blood, 2025. doi:10.1182/blood-2025-7918